Use of Chemical Enhancers for Nasal Drug Delivery

References

• Butler D. B., Ivy A. C. Method of Application of Drugs to the Nasal Mucosa. Arch. Otolar. Feb., 1944; 39(2)
   Google Scholar
• Hankiss J., Hadhazy Cs. Resorption Von Insulin Und Asthmolysin Von Der Nasenshcleimhaut. Acta Med. Sci. Hung. 1958; 12: 107–114
   PubMedGoogle Scholar
• Colaizzi J. L. Pharmacokinetics of Intranasal Drug Administration. Transnasal Systemic Medications, Y. W. Chien, S. F. Chang. Elsevier. 1985
   Google Scholar
• Delivery Systems for Peptide Drugs, S. S. Davis, L. Ilium, E. Tomlinson. Plenum Press. 1987; 98
   Google Scholar
• Chan R. L., et al. Absorption and Metabolism of Nafarelin, a Potent Agonist of Gonadotropin–Releasing Hormone. Clin. Pharmacol. Ther. Sept., 1988; 275–282
   PubMed Web of Science ®Google Scholar
• Proctor D. F. Nasal Physiology in Intranasal Drug Administration. Transnasal Systemic Medications, Y. W. Chien, S. F. Chang. Elsevier. 1985
   Google Scholar
• Proctor D. F. The Upper Airways. I. Nasal Physiology and Defence of the Lungs. Am. Rev. Respir. Dis. 1977; 115: 97–129
   PubMed Web of Science ®Google Scholar
• Lee S. W., et al. Nasal Sprays and Polyps. Nuclear Medicine Comm. 1984; 5: 697–703
   Web of Science ®Google Scholar
• Mygind N. Aerosol Distribution in the Nose. Rhinology 1978; XVI: 79–88
   Google Scholar
• Lee V. H. L. Enzymatic Barriers to Peptide and Protein Absorption and the Use of Penetration Enhancers to Modify Absorption. Delivery Systems for Peptide Drugs. Plenum, New York 1986
   Google Scholar
• Batts A. H. The Effect of Some Preservatives Used in Nasal Preparations on Mucociliary Clearance. J. Pharm. Pharmacol. 1989; 41: 156–159
   PubMed Web of Science ®Google Scholar
• Hermens A. J. J., Merkus W. H. M. The Influence of Drugs on Nasal Ciliary Movement. Pharmaceutical Research 1987; 4(6)445–449
   PubMed Web of Science ®Google Scholar
• Moren F. Dosage Forms and Formulations for Drug Administration to the Respiratory Tract. Drug Development Ind. Pharm. 1987; 13: 691–728
   Google Scholar
• Beskid G., et al. Enteral, oral, and rectal absorption of ceftriaxone using glyceride enhancers. Chemotheraphy 1988; 34: 77–84
   PubMed Web of Science ®Google Scholar
• Muranushi N., Nakajima Y., Kinugawa M., Muranishi S., Sezaki. Mechanism for the inducement of intestinal absorption of poorly absorbed drugs by mixed micelles. II. Effect of the incorporation of various lipids on the permeability of liposomal membranes. Int. J. Pharm. 1980; 4: 281–290
   Google Scholar
• Dimagno, et al. Effect of bile acids, lecithin and monoolein on amino acid absorption from the human duodenum. Proc. Soc. Exp. Biol. Med. 1977; 154(3)325–330
   PubMed Web of Science ®Google Scholar
• Gordon G. S., et al. Nasal Absorption of Insulin: Enhancement by Hydrophobic Bile Salts. Proc. Natl. Acad. Sci. U. S. A. 1985; 82: 7419–7423
   PubMed Web of Science ®Google Scholar
• Hersey S. J., Jackson R. T. Effect of Bile Salts on Nasal Permeability in Vitro. J. Pharm. Sci. 1987; 76(12)876–879
   PubMed Web of Science ®Google Scholar
• Martin G. P., et al. Direct Effects of Bile Salts and Phospholipids on the Physical Properties of Mucus. Gut 1978; 19: 103–107
   PubMed Web of Science ®Google Scholar
• Hirai S., et al. Mechanism for the Enhancement of the Nasal Absorption of Insulin. Int. J. Pharm. 1981; 9: 173–184
   Web of Science ®Google Scholar
• Hanson M., et al. Intranasal Delivery of the Peptide, Salmon Calcitonin. Delivery Systems for Peptide Drugs, S. S. Davis, L. Ilium, E. Tomlinson. Plenum Press. 1987
   Google Scholar
• Duchateau G. S. M. J. E., et al. Bile Salts and Intranasal Drug Absorption. Int. J. Pharm. 1986; 31: 193–199
   Web of Science ®Google Scholar
• Duchateau G. S. M. J. E., et al. Correlation between Ciliary Beat Frequency and Mucus Transport Rate in Volunteers. laryngoscope 1985; 95: 854–859
   PubMed Web of Science ®Google Scholar
• Hirai S., et al. Effect of Surfactants on the Nasal Absorption of Insulin in Rats. Int. J. Pharm. 1981; 9: 165–172
   Web of Science ®Google Scholar
• Moses A. C., et al. Insulin Administered Intranasally as an Insulin–Bile Salt Aerosol. Effectiveness and Reproducibility in Normal and Diabetic Subjects. Diabetes 1983; 32: 1040–1047
   PubMed Web of Science ®Google Scholar
• Fischer A. N. The Effect of Molecular Size on the Nasal Absorption of Water–Soluble Compounds in the Albino Rat. J. Pharm. Pharmacol. 1987; 39: 357–362
   PubMed Web of Science ®Google Scholar
• Duchateau G. S. M. J. E., et al. Influence of some surface–active agents on nasal absorption in rabbits. Int. J. Pharm. 1987; 39: 87–92
   Web of Science ®Google Scholar
• Sakai K., Kutsuna T. M., Nishino T., Fujihara Y., Yata. Contribution of calcium ion sequestration by polyoxyethylated non–ionic surfactants to the enhanced colonic absorption of p–aminobenzoic acid. J. Pharm. Sci. 1986; 75: 387–390
   PubMed Web of Science ®Google Scholar
• Longenecker J. P. NAZLIN–Transnasal Systemic Delivery of Insulin. Delivery Systems for Peptide Drugs, S. S. Davis, L. Ilium, E. Tomlinson. Plenum Press. 1987
   Google Scholar
• Daugherty A. L., Liggit H. D., Mc Cabe J. G., Moore J. A., Patton J. S. Absorption of recombinant Met–hGH from rat nasal mucose. Int. J. Pharm. 1988; 45: 197–206
   Web of Science ®Google Scholar
• Longenecker J. P., et al. Effect of Na Taurodihydrofusidate on Nasal Absorption of Insulin in Sheep. J. Pharm. Sci. 1987; 76: 351–355
   PubMed Web of Science ®Google Scholar
• Ilium L., et al. Nasal Administration of Gentamicin Using a Novel Microsphere Delivery System. Int. J. Pharm. 1988; 46: 261–265
   Web of Science ®Google Scholar
• Davenport H. W. Destruction of the Gastric Mucosal Barrier by Detergents and Urea. Gastroenterology 1968; 54: 175–181
   PubMed Web of Science ®Google Scholar
• Davenport H. W. Effect of Lysolecithin, Digitonin, and Phospholipase upon the Dog's Gastric Mucosal Barrier. Gastroenterology 1970; 59: 505–509
   PubMed Web of Science ®Google Scholar
• Raehs S. C., et al. Absorption Enhancement of Bacitracin upon Nasal Absorption of GHRH in Rats. Proceeding of the 15th International Symposium on Controlled Release of Bioactive Materials, Basel, August, 15–191988
   Google Scholar
• Sekine K., et al. Pharmaceutical Powdery Compositions Containing Physiologically Active Polypeptides for Intranasal Administration. Jpn. Kokai Tokkyo Koho JP 1986; 63: 115, 822, [88, 115, 822], (CA Vol.110, page 429, 1989)
   Google Scholar
• Kowarski H. R. Pharmaceutical Ccsnnposition and Method for Intranasal Administration, EPA. 0285367, 1988
   Google Scholar
• Yoshioka H., Fujita T., Goto A. Effect of Glycyrrhizin on the phosphatidylcholine–Water System. ESR and Calorimetric Study. J. Colloid Interface Science 1989; 133(2)442–446
   Web of Science ®Google Scholar
• Japanese Kokai JP. 63, 010, 735, 10.01.1988
   Google Scholar
• Ohwaki T., et al. Effect of Dose, pH and Osmolarity on Nasal Absorption of Secretin in Rats. II. Histological Aspects of the Nasal Mucosa in Relation to the Absorption Variation due to the Effects of pH and Osmolarity. J. Pharm. Sci. 1987; 76(9)695–698
   PubMed Web of Science ®Google Scholar
• Ilium L., et al. Bioadhesive Microspheres as a Potential Nasal Drug Delivery System. Int. J. Pharm. 1987; 39: 189–199
   Web of Science ®Google Scholar
• Bjork E., Edman P. Degradable Starch Microspheres as a Nasal Delivery System for Insulin. Int. J. Pharm. 1988; 47: 233–238
   Web of Science ®Google Scholar
• Ilium L., et al. Microspheres as a Nasal Drug Delivery System. Proceedings of the 15th International Synposium on Controlled Delivery of Bioactive Material, Basel, August, 15–191988
   Google Scholar
• Morunoto K., et al. Enhancement of Nasal Absorption of Insulin and Calcitonin Using Polyacrylic Acid Gel. J. Pharm. Pharmacol. 1985; 37: 134–136
   PubMed Web of Science ®Google Scholar
• Pennington A. K., et al. The influence of Solution Viscosity on Nasal Spray Deposition and Clearance. Int. J. Pharm. 1988; 43: 221–224
   Web of Science ®Google Scholar
• Hammami M., et al. Expression of ACTH–Induced Corticosteroid Biosynthesis in Newborn Rat Adrenocortical Cells Cultured in Serum–Free and Carrier–Free Medium Containing a Cholesterol–α–Cyclodextrin Complex. Cel Biol. Toxicol. 1986; 2(1)41–52
   PubMed Web of Science ®Google Scholar
• Edgar H. P., Sorensen A. R. Nasal Formulations and a Process for Preparation therof, EPA#. 87311054.8, 1987
   Google Scholar
• Van de Donk H. J. M., et al. The Effect of Preservatives on the ciliary Beat Frequency of Chicken Embryo Tracheas. Rhinology 1980; 18: 119–133, 42) Van de Donk H. J. M., et al., “The Influence of the pH and Osmotic Pressure upon Tracheal Ciliary Beat Frequency as Determinated with a New Photo–Electric Registration Device”, Rhinology 18, 93–104, (1980)
   PubMedGoogle Scholar
• Lee S. W., et al. Nasal Sprays and Polyps. Nucl. Med. Commun. 1984; 5: 697–703
   Web of Science ®Google Scholar
• Buri I. P. Hydrogels destinés à la inuqueuse nasale. Controle physiologique. Pharm. Acta Helvetiae 1966; 41: 88–101
   PubMedGoogle Scholar
• Lee W. A., Longenecker J. P. Intranasal Delivery of Proteins and Peptides. BioPharm APRIL, 1988; 30–37
   Google Scholar